๐Ÿ”ฌDeep Research

IBRX โ€” ImmunityBio ยท catalysts, narrative & risks

ยท28 sourcesIBRX forecast โ†’

ImmunityBio (IBRX) โ€” Research Summary as of October 30, 2026

Current Snapshot

As of the last trading session (October 29, 2026), IBRX closed around $8.74โ€“$8.81, with a market capitalization of approximately $9.26B [15], [20], [26]. The stock trades within a 52-week range of $1.95โ€“$12.43 and has posted extraordinary recent returns โ€” year-to-date around +341% and a 1-year total return near +261%, reflecting a massive run-up that has already priced in substantial optimism [15]. (Some sources cite higher figures, e.g., +382% YTD / +285% 1-year, but all point to the same conclusion of an aggressive rally) [8]. The date is confirmed as of October 30, 2026 [30].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’